Skip to main content
Signal8

Davarpanah Nicole Negar

SEC insider (Form 3/4/5 filer). CIK 0002067554. Chief Medical Officer at Cidara Therapeutics, Inc. (CDTX). 6 reported Form 4/5 transactions since Sep 2024; latest on Jan 7, 2026. Located in SAN DIEGO, CA.

Companies Davarpanah Nicole Negar has filed insider reports for

  • Cidara Therapeutics, Inc. (CDTX): Officer, Chief Medical Officer
Davarpanah Nicole Negar profile photo

Davarpanah Nicole Negar

CIK: 0002067554

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (16.7%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (16.7%)

Compensation grants

Other (G, F, J, C, D, …)4 (66.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Cidara Therapeutics, Inc. logo
CDTX

Cidara Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • Cidara Therapeutics, Inc. logo
    CDTX

    Cidara Therapeutics, Inc.

    Jan 7, 2026
    Disposition
    Direct
    12.6K shares at avg. $221.50$2.8M
  • Cidara Therapeutics, Inc. logo
    CDTX

    Cidara Therapeutics, Inc.

    Jan 7, 2026
    Disposition
    Direct
    8.3K shares-
  • Cidara Therapeutics, Inc. logo
    CDTX

    Cidara Therapeutics, Inc.

    Dec 29, 2025
    Gift
    Direct
    450 shares-
  • Cidara Therapeutics, Inc. logo
    CDTX

    Cidara Therapeutics, Inc.

    Dec 10, 2025
    Tax Payment
    Direct
    10.3K shares at avg. $219.60$2.3M
  • Cidara Therapeutics, Inc. logo
    CDTX

    Cidara Therapeutics, Inc.

    Sep 11, 2025
    Sale
    Direct
    474 shares at avg. $62.86$30K
  • Cidara Therapeutics, Inc. logo
    CDTX

    Cidara Therapeutics, Inc.

    May 1, 2025
    Award
    Direct
    10K shares-

1-6 of 6